Pharama analyst, Anmol Ganjoo beleives that acceptence of this felony charges will not only be sentiment negative for Ranbaxy but it will hit their brand name too.
first published: May 14, 2013 10:26 am
A collection of the most-viewed Moneycontrol videos.

Market Braces For Tough Session Amid AI-Led Global Tech Rout | RBI Policy Today | Opening Bell Live

Live: Nifty slips below 25,650 amid broad-based selloff; IT continues freefall | Closing Bell

Can Nifty Power Ahead For Fourth Day Despite Anthropic-Led Tech Jitters? | Opening Bell Live

Investing for a new era | LIVE conversation with Mukesh Ambani & Larry Fink
You are already a Moneycontrol Pro user.